FDA Oks Generic Versions of Antibiotic Levaquin
From Associated Press (June 20, 2011)
SILVER SPRING, Md. -- The Food and Drug Administration said Monday it approved the first generic versions of Johnson & Johnson's antibiotic Levaquin, which treats bacterial infections that cause bronchitis or pneumonia.
The antibiotic, known generically as levofloxacin, also treats infections of the skin, sinuses, kidney, bladder and prostate. Regulators approved applications from 12 manufacturers for generic versions of the drug. Those companies include Akorn Inc., Dr. Reddy's Laboratories Ltd., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA.
Levaquin is made by Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of New Brunswick, N.J.-based Johnson & Johnson.
J&J shares ended Monday up 22 cents to $66.51.
Posted: June 2011